Patents by Inventor Sylvain Lengacher

Sylvain Lengacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isoquinoline derivatives for use in treating GLUT1 deficiency syndrome
    Patent number: 11925632
    Abstract: The present invention relates to new agents useful for the prevention and/or treatment of GLUT1-DS and related methods using the same.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: March 12, 2024
    Assignee: GLIAPHARM SA
    Inventors: Pierre Magistretti, Sylvain Lengacher, Charles Finsterwald, Timothy John Ritchie
  • ISOQUINOLINE DERIVATIVES FOR USE IN TREATING GLUT1 DEFICIENCY SYNDROME
    Publication number: 20230102415
    Abstract: The present invention relates to new agents useful for the prevention and/or treatment of GLUT1-DS and related methods using the same.
    Type: Application
    Filed: December 29, 2020
    Publication date: March 30, 2023
    Inventors: PIERRE MAGISTRETTI, SYLVAIN LENGACHER, CHARLES FINSTERWALD, TIMOTHY JOHN RITCHIE
  • COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING DEPRESSION
    Publication number: 20220040186
    Abstract: This invention, in at least some embodiments, relates to an inventive molecule, compositions comprising same, and methods of use thereof for treatment of a neurological disorder.
    Type: Application
    Filed: June 22, 2021
    Publication date: February 10, 2022
    Inventors: Sylvain LENGACHER, Charles FINSTERWALD, Pierre MAGISTRETTI
  • COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING A DEMENTIA
    Publication number: 20220040197
    Abstract: This invention, in at least some embodiments, relates to an inventive molecule, compositions comprising same, and methods of use thereof for treatment of a neurological disorder.
    Type: Application
    Filed: August 24, 2021
    Publication date: February 10, 2022
    Inventors: Sylvain LENGACHER, Charles FINSTERWALD, Pierre MAGISTRETTI
  • COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING MOTOR NEURON DISEASES
    Publication number: 20220040189
    Abstract: This invention, in at least some embodiments, relates to an inventive molecule, compositions comprising same, and methods of use thereof for treatment of a neurological disorder.
    Type: Application
    Filed: August 24, 2021
    Publication date: February 10, 2022
    Inventors: Sylvain LENGACHER, Charles FINSTERWALD, Pierre MAGISTRETTI
  • LACTATE ENHANCING COMPOUNDS AND USES THEREOF
    Publication number: 20210275516
    Abstract: The present invention relates to new agents useful for stimulating release of lactate by astrocytes. The invention further relates to methods of preparation, formulations and therapeutic uses of those agents, notably for the prevention and/or treatment of neurological disorders, in particular neurodegenerative and psychiatric disorders or improving cognitive and memory functions.
    Type: Application
    Filed: July 1, 2019
    Publication date: September 9, 2021
    Inventors: PIERRE MAGISTRETTI, SYLVAIN LENGACHER, CHARLES FINSTERWALD
  • COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING A DEMENTIA
    Publication number: 20200339591
    Abstract: This invention, in at least some embodiments, relates to an inventive molecule, compositions comprising same, and methods of use thereof for treatment of a neurological disorder.
    Type: Application
    Filed: December 20, 2018
    Publication date: October 29, 2020
    Inventors: Sylvain LENGACHER, Charles FINSTERWALD, Pierre MAGISTRETTI
  • COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING MOTOR NEURON DISEASES
    Publication number: 20200325148
    Abstract: This invention, in at least some embodiments, relates to an inventive molecule, compositions comprising same, and methods of use thereof for treatment of a neurological disorder.
    Type: Application
    Filed: December 20, 2018
    Publication date: October 15, 2020
    Inventors: Sylvain LENGACHER, Charles FINSTERWALD, Pierre MAGISTRETTI
  • 4-oxo-2-pentenoic acid and brain health
    Patent number: 9259404
    Abstract: The present invention relates generally to compositions with a health benefit. In particular, the invention relates to the field of brain health, for example brain protection, maintenance of cognitive function, prevention of cognitive decline and prevention of cognitive disorders. A subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of cognitive decline.
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: February 16, 2016
    Assignee: Nestec S.A.
    Inventors: Francia Jacqueline Arce Vera, Bertrand Bourqui, Timo Buetler, Stephane Duboux, Jane Durga, Francis Foata, Philippe Alexandre Guy, Nicolas Page, Serge Andre Dominique Rezzi, Pierre Magistretti, Evelyne Ruchti, Sylvain Lengacher, Igor Allaman
  • 4-OXO-2-PENTENOIC ACID AND BRAIN HEALTH
    Publication number: 20150105464
    Abstract: The present invention relates generally to compositions with a health benefit. In particular, the invention relates to the field of brain health, for example brain protection, maintenance of cognitive function, prevention of cognitive decline and prevention of cognitive disorders. A subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of cognitive decline.
    Type: Application
    Filed: March 25, 2013
    Publication date: April 16, 2015
    Applicant: NESTEC S.A.
    Inventors: Francia Jacqueline Arce Vera, Bertrand Bourqui, Timo Buetler, Stephane Duboux, Jane Durga, Francis Foata, Philippe Alexandre Guy, Nicolas Page, Serge Andre Dominique Rezzi, Pierre Magistretti, Evelyne Ruchti, Sylvain Lengacher, Igor Allaman